_id
69147bf0ccc777a4e85d90c1
Ticker
MRSN
Name
Mersana Therapeutics Inc
Exchange
NASDAQ
Address
840 Memorial Drive, Cambridge, MA, United States, 02139
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.mersana.com
Description
Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops antibody-drug conjugates (ADC) for cancer patients with unmet needs. The company develops Emi-Le (XMT-1660), a B7-H4-targeting Dolasynthen ADC candidate, which is in Phase 1 clinical trial; and XMT-2056, an Immunosynthen ADC targeting a novel human epidermal growth factor receptor 2 that is in Phase 1 clinical trial. Its preclinical products portfolio includes XMT-2068 and XMT-2175. It has strategic research and development collaborations with Janssen Biotech, Inc., Ares Trading S.A., Merck KGaA, and Asana Biosciences, LLC for the development of ADC product candidates. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.
Last Close
28.23
Volume
64951
Current Price
28.35
Change
0.42507970244421184
Last Updated
2025-12-02T12:07:43.271Z
Image
data:image/webp;base64,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
Ipo Date
2017-06-28T00:00:00.000Z
Market Cap
137115712
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.822
Sentiment Sources
15
Rating
4.7778
Target Price
33.2
Strong Buy
8
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
11009000
Cost Of Revenue
-
Gross Profit
11009000
Operating Expenses
18485000
Operating Income
-7476000
Interest Expense
394000
Pretax Income
-7545000
Net Income
-7545000
Eps
-1.512999159378068
Dividends Per Share
-
Shares Outstanding
4998750
Income Tax Expense
-
EBITDA
-7068000
Operating Margin
-67.90807521119085
Total Other Income Expense Net
-69000
Cash
56391000
Short Term Investments
0
Receivables
168000
Inventories
-
Total Current Assets
59988000
Property Plant Equipment
2198000
Total Assets
62686000
Payables
2393000
Short Term Debt
2293000
Long Term Debt
-
Total Liabilities
122223000
Equity
-59537000
Depreciation
83000
Change In Working Capital
1857000
Cash From Operations
-3192000
Capital Expenditures
0
Cash From Investing
372000
Cash From Financing
-17761000
Net Change In Cash
-20581000
PE
-
PB
-2.3745792767522715
ROE
12.672791709357206
ROA
-12.03618032734582
FCF
-3192000
Fcf Percent
-0.28994459078935414
Piotroski FScore
1
Health Score
25
Deep Value Investing Score
1.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
3.5
Growth Investing Score
3
Momentum Investing Score
3.5
Net Net Investing Score
1
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
11009000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
11009000
Quarters > 0 > income Statement > operating Expenses
18485000
Quarters > 0 > income Statement > operating Income
-7476000
Quarters > 0 > income Statement > interest Expense
394000
Quarters > 0 > income Statement > pretax Income
-7545000
Quarters > 0 > income Statement > net Income
-7545000
Quarters > 0 > income Statement > eps
-1.512999159378068
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
4986784
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-7068000
Quarters > 0 > income Statement > operating Margin
-67.90807521119085
Quarters > 0 > income Statement > total Other Income Expense Net
-69000
Quarters > 0 > balance Sheet > cash
56391000
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
168000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
59988000
Quarters > 0 > balance Sheet > property Plant Equipment
2198000
Quarters > 0 > balance Sheet > total Assets
62686000
Quarters > 0 > balance Sheet > payables
2393000
Quarters > 0 > balance Sheet > short Term Debt
2293000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
122223000
Quarters > 0 > balance Sheet > equity
-59537000
Quarters > 0 > cash Flow > net Income
-7545000
Quarters > 0 > cash Flow > depreciation
83000
Quarters > 0 > cash Flow > change In Working Capital
1857000
Quarters > 0 > cash Flow > cash From Operations
-3192000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
372000
Quarters > 0 > cash Flow > cash From Financing
-17761000
Quarters > 0 > cash Flow > net Change In Cash
-20581000
Quarters > 0 > ratios > PE
-1.512999159378068
Quarters > 0 > ratios > PB
-2.3745792767522715
Quarters > 0 > ratios > ROE
12.672791709357206
Quarters > 0 > ratios > ROA
-12.03618032734582
Quarters > 0 > ratios > FCF
-3192000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.28994459078935414
Quarters > 0 > health Score
25
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
3056000
Quarters > 1 > income Statement > cost Of Revenue
287000
Quarters > 1 > income Statement > gross Profit
2769000
Quarters > 1 > income Statement > operating Expenses
23346000
Quarters > 1 > income Statement > operating Income
-20577000
Quarters > 1 > income Statement > interest Expense
674000
Quarters > 1 > income Statement > pretax Income
-24296000
Quarters > 1 > income Statement > net Income
-24296000
Quarters > 1 > income Statement > eps
-4.872077876242484
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
4986784
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-23335000
Quarters > 1 > income Statement > operating Margin
-673.3311518324608
Quarters > 1 > income Statement > total Other Income Expense Net
-3719000
Quarters > 1 > balance Sheet > cash
76972000
Quarters > 1 > balance Sheet > short Term Investments
0
Quarters > 1 > balance Sheet > receivables
266000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
80141000
Quarters > 1 > balance Sheet > property Plant Equipment
3932000
Quarters > 1 > balance Sheet > total Assets
84573000
Quarters > 1 > balance Sheet > payables
2923000
Quarters > 1 > balance Sheet > short Term Debt
20621000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
137719000
Quarters > 1 > balance Sheet > equity
-53146000
Quarters > 1 > cash Flow > net Income
-24296000
Quarters > 1 > cash Flow > depreciation
287000
Quarters > 1 > cash Flow > change In Working Capital
-2067000
Quarters > 1 > cash Flow > cash From Operations
-22602000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
395000
Quarters > 1 > cash Flow > cash From Financing
-3108000
Quarters > 1 > cash Flow > net Change In Cash
-25315000
Quarters > 1 > ratios > PE
-4.872077876242484
Quarters > 1 > ratios > PB
-2.660131080419975
Quarters > 1 > ratios > ROE
45.71557596056147
Quarters > 1 > ratios > ROA
-28.72784458396888
Quarters > 1 > ratios > FCF
-22602000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-7.395942408376963
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
2754000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
2754000
Quarters > 2 > income Statement > operating Expenses
27266000
Quarters > 2 > income Statement > operating Income
-24512000
Quarters > 2 > income Statement > interest Expense
775000
Quarters > 2 > income Statement > pretax Income
-24123000
Quarters > 2 > income Statement > net Income
-24123000
Quarters > 2 > income Statement > eps
-4.84529522496487
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
4978644
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-23032000
Quarters > 2 > income Statement > operating Margin
-890.0508351488744
Quarters > 2 > income Statement > total Other Income Expense Net
389000
Quarters > 2 > balance Sheet > cash
102287000
Quarters > 2 > balance Sheet > short Term Investments
0
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
106188000
Quarters > 2 > balance Sheet > property Plant Equipment
5626000
Quarters > 2 > balance Sheet > total Assets
112471000
Quarters > 2 > balance Sheet > payables
4374000
Quarters > 2 > balance Sheet > short Term Debt
16461000
Quarters > 2 > balance Sheet > long Term Debt
7901000
Quarters > 2 > balance Sheet > total Liabilities
143339000
Quarters > 2 > balance Sheet > equity
-30868000
Quarters > 2 > cash Flow > net Income
-24123000
Quarters > 2 > cash Flow > depreciation
316000
Quarters > 2 > cash Flow > change In Working Capital
-9069000
Quarters > 2 > cash Flow > cash From Operations
-29326000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
27000000
Quarters > 2 > cash Flow > cash From Financing
-3137000
Quarters > 2 > cash Flow > net Change In Cash
-5463000
Quarters > 2 > ratios > PE
-4.84529522496487
Quarters > 2 > ratios > PB
-4.572520325255929
Quarters > 2 > ratios > ROE
78.14889205649864
Quarters > 2 > ratios > ROA
-21.44819553484898
Quarters > 2 > ratios > FCF
-29326000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-10.648511256354393
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
16361000
Quarters > 3 > income Statement > cost Of Revenue
400000
Quarters > 3 > income Statement > gross Profit
16361000
Quarters > 3 > income Statement > operating Expenses
31172000
Quarters > 3 > income Statement > operating Income
-14811000
Quarters > 3 > income Statement > interest Expense
903000
Quarters > 3 > income Statement > pretax Income
-14117000
Quarters > 3 > income Statement > net Income
-14117000
Quarters > 3 > income Statement > eps
-2.8563462400714803
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
4942328
Quarters > 3 > income Statement > income Tax Expense
-1215724
Quarters > 3 > income Statement > EBITDA
-12814000
Quarters > 3 > income Statement > operating Margin
-90.52625145162277
Quarters > 3 > income Statement > total Other Income Expense Net
694000
Quarters > 3 > balance Sheet > cash
107750000
Quarters > 3 > balance Sheet > short Term Investments
26870000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
136904000
Quarters > 3 > balance Sheet > property Plant Equipment
6781000
Quarters > 3 > balance Sheet > total Assets
144663000
Quarters > 3 > balance Sheet > payables
4330000
Quarters > 3 > balance Sheet > short Term Debt
16356000
Quarters > 3 > balance Sheet > long Term Debt
10950000
Quarters > 3 > balance Sheet > total Liabilities
154172000
Quarters > 3 > balance Sheet > equity
-9509000
Quarters > 3 > cash Flow > net Income
-14117000
Quarters > 3 > cash Flow > depreciation
400000
Quarters > 3 > cash Flow > change In Working Capital
-9187000
Quarters > 3 > cash Flow > cash From Operations
-19251000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
50000000
Quarters > 3 > cash Flow > cash From Financing
-1867000
Quarters > 3 > cash Flow > net Change In Cash
28882000
Quarters > 3 > ratios > PE
-2.8563462400714803
Quarters > 3 > ratios > PB
-14.734987779997898
Quarters > 3 > ratios > ROE
148.45935429593018
Quarters > 3 > ratios > ROA
-9.75854226720032
Quarters > 3 > ratios > FCF
-19251000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-1.176639569708453
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
40497000
Annuals > 0 > income Statement > cost Of Revenue
1628000
Annuals > 0 > income Statement > gross Profit
40497000
Annuals > 0 > income Statement > operating Expenses
113833000
Annuals > 0 > income Statement > operating Income
-73336000
Annuals > 0 > income Statement > interest Expense
3874000
Annuals > 0 > income Statement > pretax Income
-68774000
Annuals > 0 > income Statement > net Income
-69192000
Annuals > 0 > income Statement > eps
-14.116255911610596
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
4901583
Annuals > 0 > income Statement > income Tax Expense
418000
Annuals > 0 > income Statement > EBITDA
-63272000
Annuals > 0 > income Statement > operating Margin
-181.08995728078622
Annuals > 0 > income Statement > total Other Income Expense Net
4562000
Annuals > 0 > balance Sheet > cash
107750000
Annuals > 0 > balance Sheet > short Term Investments
26870000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
136904000
Annuals > 0 > balance Sheet > property Plant Equipment
6781000
Annuals > 0 > balance Sheet > total Assets
144663000
Annuals > 0 > balance Sheet > payables
4330000
Annuals > 0 > balance Sheet > short Term Debt
16356000
Annuals > 0 > balance Sheet > long Term Debt
10950000
Annuals > 0 > balance Sheet > total Liabilities
154172000
Annuals > 0 > balance Sheet > equity
-9509000
Annuals > 0 > cash Flow > net Income
-69192000
Annuals > 0 > cash Flow > depreciation
1628000
Annuals > 0 > cash Flow > change In Working Capital
-30738000
Annuals > 0 > cash Flow > cash From Operations
-82340000
Annuals > 0 > cash Flow > capital Expenditures
132000
Annuals > 0 > cash Flow > cash From Investing
11437000
Annuals > 0 > cash Flow > cash From Financing
4092000
Annuals > 0 > cash Flow > net Change In Cash
-66811000
Annuals > 0 > ratios > PE
-14.116255911610596
Annuals > 0 > ratios > PB
-14.139280859186034
Annuals > 0 > ratios > ROE
727.6474918498265
Annuals > 0 > ratios > ROA
-47.829783704195265
Annuals > 0 > ratios > FCF
-82472000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-2.0364965306072054
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
36855000
Annuals > 1 > income Statement > cost Of Revenue
148269000
Annuals > 1 > income Statement > gross Profit
36855000
Annuals > 1 > income Statement > operating Expenses
207812000
Annuals > 1 > income Statement > operating Income
-170957000
Annuals > 1 > income Statement > interest Expense
4073000
Annuals > 1 > income Statement > pretax Income
-171670000
Annuals > 1 > income Statement > net Income
-171670000
Annuals > 1 > income Statement > eps
-36.961873595930015
Annuals > 1 > income Statement > dividends Per Share
94937000
Annuals > 1 > income Statement > shares Outstanding
4644515.64
Annuals > 1 > income Statement > income Tax Expense
1349105
Annuals > 1 > income Statement > EBITDA
-166080000
Annuals > 1 > income Statement > operating Margin
-463.8637905304572
Annuals > 1 > income Statement > total Other Income Expense Net
-713000
Annuals > 1 > balance Sheet > cash
174561000
Annuals > 1 > balance Sheet > short Term Investments
34523000
Annuals > 1 > balance Sheet > receivables
0
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
214057000
Annuals > 1 > balance Sheet > property Plant Equipment
11525000
Annuals > 1 > balance Sheet > total Assets
226060000
Annuals > 1 > balance Sheet > payables
7319000
Annuals > 1 > balance Sheet > short Term Debt
5479000
Annuals > 1 > balance Sheet > long Term Debt
23148000
Annuals > 1 > balance Sheet > total Liabilities
189156000
Annuals > 1 > balance Sheet > equity
36904000
Annuals > 1 > cash Flow > net Income
-171670000
Annuals > 1 > cash Flow > depreciation
1517000
Annuals > 1 > cash Flow > change In Working Capital
-18763000
Annuals > 1 > cash Flow > cash From Operations
-168882000
Annuals > 1 > cash Flow > capital Expenditures
2168000
Annuals > 1 > cash Flow > cash From Investing
119883000
Annuals > 1 > cash Flow > cash From Financing
94675000
Annuals > 1 > cash Flow > net Change In Cash
45676000
Annuals > 1 > ratios > PE
-36.961873595930015
Annuals > 1 > ratios > PB
3.452174940526772
Annuals > 1 > ratios > ROE
-465.1799262952525
Annuals > 1 > ratios > ROA
-75.94001592497567
Annuals > 1 > ratios > FCF
-171050000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-4.641161307827974
Annuals > 1 > health Score
11
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
26581000
Annuals > 2 > income Statement > cost Of Revenue
927000
Annuals > 2 > income Statement > gross Profit
26581000
Annuals > 2 > income Statement > operating Expenses
230348000
Annuals > 2 > income Statement > operating Income
-203767000
Annuals > 2 > income Statement > interest Expense
3328000
Annuals > 2 > income Statement > pretax Income
-204212000
Annuals > 2 > income Statement > net Income
-204212000
Annuals > 2 > income Statement > eps
-54.51221254332278
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
3746169.72
Annuals > 2 > income Statement > income Tax Expense
3328000
Annuals > 2 > income Statement > EBITDA
-199957000
Annuals > 2 > income Statement > operating Margin
-766.5889168955268
Annuals > 2 > income Statement > total Other Income Expense Net
-445000
Annuals > 2 > balance Sheet > cash
128885000
Annuals > 2 > balance Sheet > short Term Investments
151827000
Annuals > 2 > balance Sheet > receivables
30000000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
319219000
Annuals > 2 > balance Sheet > property Plant Equipment
14460000
Annuals > 2 > balance Sheet > total Assets
334340000
Annuals > 2 > balance Sheet > payables
13951000
Annuals > 2 > balance Sheet > short Term Debt
2798000
Annuals > 2 > balance Sheet > long Term Debt
24929000
Annuals > 2 > balance Sheet > total Liabilities
242283000
Annuals > 2 > balance Sheet > equity
92057000
Annuals > 2 > cash Flow > net Income
-204212000
Annuals > 2 > cash Flow > depreciation
927000
Annuals > 2 > cash Flow > change In Working Capital
133099000
Annuals > 2 > cash Flow > cash From Operations
-49363000
Annuals > 2 > cash Flow > capital Expenditures
2197000
Annuals > 2 > cash Flow > cash From Investing
-152716000
Annuals > 2 > cash Flow > cash From Financing
153017000
Annuals > 2 > cash Flow > net Change In Cash
-49062000
Annuals > 2 > ratios > PE
-54.51221254332278
Annuals > 2 > ratios > PB
1.1162370642058723
Annuals > 2 > ratios > ROE
-221.83212574817776
Annuals > 2 > ratios > ROA
-61.07914099419752
Annuals > 2 > ratios > FCF
-51560000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-1.9397313870809978
Annuals > 2 > health Score
21
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
43000
Annuals > 3 > income Statement > cost Of Revenue
132013000
Annuals > 3 > income Statement > gross Profit
43000
Annuals > 3 > income Statement > operating Expenses
168901000
Annuals > 3 > income Statement > operating Income
-168858000
Annuals > 3 > income Statement > interest Expense
1267000
Annuals > 3 > income Statement > pretax Income
-170060000
Annuals > 3 > income Statement > net Income
-170060000
Annuals > 3 > income Statement > eps
-60.23580102330446
Annuals > 3 > income Statement > dividends Per Share
640000
Annuals > 3 > income Statement > shares Outstanding
2823237.96
Annuals > 3 > income Statement > income Tax Expense
-855000
Annuals > 3 > income Statement > EBITDA
-167938000
Annuals > 3 > income Statement > operating Margin
-392693.0232558139
Annuals > 3 > income Statement > total Other Income Expense Net
-1202000
Annuals > 3 > balance Sheet > cash
177947000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
0
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
188898000
Annuals > 3 > balance Sheet > property Plant Equipment
14857000
Annuals > 3 > balance Sheet > total Assets
206111000
Annuals > 3 > balance Sheet > payables
12321000
Annuals > 3 > balance Sheet > short Term Debt
2303000
Annuals > 3 > balance Sheet > long Term Debt
24626000
Annuals > 3 > balance Sheet > total Liabilities
84370000
Annuals > 3 > balance Sheet > equity
121741000
Annuals > 3 > cash Flow > net Income
-170060000
Annuals > 3 > cash Flow > depreciation
855000
Annuals > 3 > cash Flow > change In Working Capital
10085000
Annuals > 3 > cash Flow > cash From Operations
-139988000
Annuals > 3 > cash Flow > capital Expenditures
648000
Annuals > 3 > cash Flow > cash From Investing
-648000
Annuals > 3 > cash Flow > cash From Financing
63646000
Annuals > 3 > cash Flow > net Change In Cash
-76990000
Annuals > 3 > ratios > PE
-60.23580102330446
Annuals > 3 > ratios > PB
0.6361161584248528
Annuals > 3 > ratios > ROE
-139.68999761789374
Annuals > 3 > ratios > ROA
-82.50893935791879
Annuals > 3 > ratios > FCF
-140636000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-3270.6046511627906
Annuals > 3 > health Score
29
Valuation > metrics > PE
-1.512999159378068
Valuation > metrics > PB
-2.3745792767522715
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
12.672791709357206
Profitability > metrics > ROA
-12.577515503100619
Profitability > metrics > Net Margin
-0.6853483513488964
Profitability > final Score
25
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-18.9746192893401
Risk > final Score
-46
Risk > verdict
High
Liquidity > metrics > Current Ratio
12.801536491677338
Liquidity > metrics > Quick Ratio
12.801536491677338
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
-92
Prev Risks > 1
-97
Prev Risks > 2
-36
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:52:09.038Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-14
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-1.51
Earnings History > 0 > eps Estimate
-0.14
Earnings History > 0 > eps Difference
-1.37
Earnings History > 0 > surprise Percent
-978.5714
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-13
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-4.87
Earnings History > 1 > eps Estimate
-0.16
Earnings History > 1 > eps Difference
-4.71
Earnings History > 1 > surprise Percent
-2943.75
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-07
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.19
Earnings History > 2 > eps Estimate
-0.18
Earnings History > 2 > eps Difference
-0.01
Earnings History > 2 > surprise Percent
-5.5556
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.11
Earnings History > 3 > eps Estimate
-0.1675
Earnings History > 3 > eps Difference
0.0575
Earnings History > 3 > surprise Percent
34.3284
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-05
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.09
Earnings History > 4 > eps Estimate
-0.185
Earnings History > 4 > eps Difference
0.095
Earnings History > 4 > surprise Percent
51.3514
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-13
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.2
Earnings History > 5 > eps Estimate
-0.17
Earnings History > 5 > eps Difference
-0.03
Earnings History > 5 > surprise Percent
-17.6471
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.16
Earnings History > 6 > eps Estimate
-0.18
Earnings History > 6 > eps Difference
0.02
Earnings History > 6 > surprise Percent
11.1111
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-28
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.16
Earnings History > 7 > eps Estimate
-0.16
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
0
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-07
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.27
Earnings History > 8 > eps Estimate
-0.36
Earnings History > 8 > eps Difference
0.09
Earnings History > 8 > surprise Percent
25
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-08
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.47
Earnings History > 9 > eps Estimate
-0.44
Earnings History > 9 > eps Difference
-0.03
Earnings History > 9 > surprise Percent
-6.8182
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-09
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.52
Earnings History > 10 > eps Estimate
-0.44
Earnings History > 10 > eps Difference
-0.08
Earnings History > 10 > surprise Percent
-18.1818
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-02-28
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.44
Earnings History > 11 > eps Estimate
-0.5
Earnings History > 11 > eps Difference
0.06
Earnings History > 11 > surprise Percent
12
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-07
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.61
Earnings History > 12 > eps Estimate
-0.09
Earnings History > 12 > eps Difference
-0.52
Earnings History > 12 > surprise Percent
-577.7778
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-08
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.55
Earnings History > 13 > eps Estimate
-0.52
Earnings History > 13 > eps Difference
-0.03
Earnings History > 13 > surprise Percent
-5.7692
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-09
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.59
Earnings History > 14 > eps Estimate
-0.32
Earnings History > 14 > eps Difference
-0.27
Earnings History > 14 > surprise Percent
-84.375
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-28
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.68
Earnings History > 15 > eps Estimate
-0.67
Earnings History > 15 > eps Difference
-0.01
Earnings History > 15 > surprise Percent
-1.4925
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-09
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.63
Earnings History > 16 > eps Estimate
-0.58
Earnings History > 16 > eps Difference
-0.05
Earnings History > 16 > surprise Percent
-8.6207
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-06
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.59
Earnings History > 17 > eps Estimate
-0.5
Earnings History > 17 > eps Difference
-0.09
Earnings History > 17 > surprise Percent
-18
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-10
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.5
Earnings History > 18 > eps Estimate
-0.39
Earnings History > 18 > eps Difference
-0.11
Earnings History > 18 > surprise Percent
-28.2051
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-02-26
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.42
Earnings History > 19 > eps Estimate
-0.32
Earnings History > 19 > eps Difference
-0.1
Earnings History > 19 > surprise Percent
-31.25
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-09
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.33
Earnings History > 20 > eps Estimate
-0.3
Earnings History > 20 > eps Difference
-0.03
Earnings History > 20 > surprise Percent
-10
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-07
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.33
Earnings History > 21 > eps Estimate
-0.3
Earnings History > 21 > eps Difference
-0.03
Earnings History > 21 > surprise Percent
-10
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-08
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.35
Earnings History > 22 > eps Estimate
-0.37
Earnings History > 22 > eps Difference
0.02
Earnings History > 22 > surprise Percent
5.4054
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-02-28
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.34
Earnings History > 23 > eps Estimate
-0.38
Earnings History > 23 > eps Difference
0.04
Earnings History > 23 > surprise Percent
10.5263
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-06
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.35
Earnings History > 24 > eps Estimate
-0.37
Earnings History > 24 > eps Difference
0.02
Earnings History > 24 > surprise Percent
5.4054
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-08
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.36
Earnings History > 25 > eps Estimate
-0.38
Earnings History > 25 > eps Difference
0.02
Earnings History > 25 > surprise Percent
5.2632
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-09
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
0.7
Earnings History > 26 > eps Estimate
-0.02
Earnings History > 26 > eps Difference
0.72
Earnings History > 26 > surprise Percent
3600
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-08
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.97
Earnings History > 27 > eps Estimate
-0.69
Earnings History > 27 > eps Difference
-0.28
Earnings History > 27 > surprise Percent
-40.5797
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-13
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
BeforeMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.75
Earnings History > 28 > eps Estimate
-0.59
Earnings History > 28 > eps Difference
-0.16
Earnings History > 28 > surprise Percent
-27.1186
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-14
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
AfterMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.54
Earnings History > 29 > eps Estimate
-0.58
Earnings History > 29 > eps Difference
0.04
Earnings History > 29 > surprise Percent
6.8966
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-05-14
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
AfterMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.54
Earnings History > 30 > eps Estimate
-0.61
Earnings History > 30 > eps Difference
0.07
Earnings History > 30 > surprise Percent
11.4754
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-03-28
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
BeforeMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.61
Earnings History > 31 > eps Estimate
-0.5
Earnings History > 31 > eps Difference
-0.11
Earnings History > 31 > surprise Percent
-22
Earnings History > 32 > period
2017-09-30
Earnings History > 32 > report Date
2017-11-09
Earnings History > 32 > date
2017-09-30
Earnings History > 32 > before After Market
AfterMarket
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.35
Earnings History > 32 > eps Estimate
-0.45
Earnings History > 32 > eps Difference
0.1
Earnings History > 32 > surprise Percent
22.2222
Earnings History > 33 > period
2017-06-30
Earnings History > 33 > report Date
2017-08-11
Earnings History > 33 > date
2017-06-30
Earnings History > 33 > before After Market
AfterMarket
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-6.33
Earnings History > 33 > eps Estimate
-0.69
Earnings History > 33 > eps Difference
-5.64
Earnings History > 33 > surprise Percent
-817.3913
Earnings History > 34 > period
2017-03-31
Earnings History > 34 > report Date
2017-06-29
Earnings History > 34 > date
2017-03-31
Earnings History > 34 > before After Market
AfterMarket
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-6.02
Earnings History > 34 > eps Estimate
-
Earnings History > 34 > eps Difference
0
Earnings History > 34 > surprise Percent
-
Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops antibody-drug conjugates (ADC) for cancer patients with unmet needs. The company develops Emi-Le (XMT-1660), a B7-H4-targeting Dolasynthen ADC candidate, which is in Phase 1 clinical trial; and XMT-2056, an Immunosynthen ADC targeting a novel human epidermal growth factor receptor 2 that is in Phase 1 clinical trial. Its preclinical products portfolio includes XMT-2068 and XMT-2175. It has strategic research and development collaborations with Janssen Biotech, Inc., Ares Trading S.A., Merck KGaA, and Asana Biosciences, LLC for the development of ADC product candidates. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWhy Analysts See Mersana’s Story Shifting To Deal And CVR Outcomes After $1B Buyout Yahoo Finance
Read more →683 Capital Management LLC Boosts Stock Position in Mersana Therapeutics, Inc. $MRSN - MarketBeat
12/13/2025
683 Capital Management LLC Boosts Stock Position in Mersana Therapeutics, Inc. $MRSN MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$33.2
Analyst Picks
Strong Buy
8
Buy
0
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 65.48% of the total shares of Mersana Therapeutics Inc
1.
Nextech Invest, Ltd.(9.6718%)
since
2025/03/31
2.
Bain Capital Life Sciences Investors, LLC(6.9439%)
since
2025/03/31
3.
Vanguard Group Inc(6.7147%)
since
2025/03/31
4.
BlackRock Inc(6.6734%)
since
2025/03/31
5.
Schonfeld Strategic Advisors LLC(6.1026%)
since
2025/03/31
6.
AQR Capital Management LLC(4.1227%)
since
2025/03/31
7.
Rock Springs Capital Management LP(3.0574%)
since
2025/03/31
8.
Vanguard Total Stock Mkt Idx Inv(2.7224%)
since
2025/07/31
9.
SILVERARC CAPITAL MANAGEMENT, LLC(2.4754%)
since
2025/03/31
10.
State Street Corp(2.087%)
since
2025/03/31
11.
Geode Capital Management, LLC(1.9575%)
since
2025/03/31
12.
Vanguard Explorer Inv(1.6085%)
since
2025/06/30
13.
Catalio Capital Management, LP(1.3666%)
since
2025/03/31
14.
683 Capital Management LLC(1.3225%)
since
2025/03/31
15.
Jacobs Levy Equity Management, Inc.(1.0685%)
since
2025/03/31
16.
5AM Venture Management, LLC(1.0459%)
since
2025/03/31
17.
Qube Research & Technologies(0.9414%)
since
2025/03/31
18.
Vanguard Institutional Extnd Mkt Idx Tr(0.8396%)
since
2025/07/31
19.
Northern Trust Corp(0.6931%)
since
2025/03/31
20.
Renaissance Technologies Corp(0.6732%)
since
2025/03/31
21.
Deutsche Bank AG(0.673%)
since
2025/03/31
22.
IEQ CAPITAL, LLC(0.5667%)
since
2025/03/31
23.
Lion Point Capital, LP(0.5162%)
since
2025/03/31
24.
iShares Biotechnology ETF(0.4793%)
since
2025/08/31
25.
Vanguard VIF Small Co Gr(0.3273%)
since
2025/06/30
26.
Extended Equity Market Fund K(0.1675%)
since
2025/06/30
27.
Vanguard Market Neutral I(0.0947%)
since
2025/06/30
28.
NT Ext Equity Mkt Idx Fd - L(0.0848%)
since
2025/06/30
29.
Northern Trust Extended Eq Market Idx(0.0848%)
since
2025/06/30
30.
NT Ext Equity Mkt Idx Fd - NL(0.0692%)
since
2025/06/30
31.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0538%)
since
2025/06/30
32.
NT Col R2000 Val Idx Fd -DC -L -TierFour(0.0452%)
since
2025/03/31
33.
Vanguard Instl Ttl Stck Mkt Idx Tr(0.0415%)
since
2024/12/31
34.
Russell 2500â„¢ Index Fund F(0.0395%)
since
2025/06/30
35.
U.S. Equity Market Fund F(0.0328%)
since
2025/06/30
36.
Russell 2000 Index Non-Lendable Fund E(0.0326%)
since
2025/06/30
37.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0239%)
since
2025/06/30
38.
Extended Equity Market Fund M(0.0211%)
since
2025/06/30
39.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0202%)
since
2024/12/31
40.
China Universal NASDAQ Bio-Tch ETF(QDII)(0.0201%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-1.51
EPS Estimate
-0.14
EPS Difference
-1.37
Surprise Percent
-978.5714%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.